Wednesday, April 22, 2026
26.8 C
Bengaluru

A Social Experiment

MedicinMan May 2015

[wpfilebase tag=file id=47 tpl=download-button /]

Inside this Issue

1. Doctor Profiling for Sales Success by RB Balakrishna

A Doctor Profile enables the Medical Rep to tailor-make his detailing approach to each Doctor, ensuring sales success.

2.  Using Gamification to Achieve a State of Flow while Learning by Rajiv Jayaraman

By turning learning into a game, learners enter into a ‘state of flow’ – a condition where the ‘high’ of the game makes learning a habit.

3.  The 3 ‘E’s of Sales Leadership: Engage,  Empower &  Enable by K. Hariram

How to move from being mere sales ‘managers’ to being sales ‘leaders’.

4.  Focus Feature: Brand Life Cycle Management by Vivek Hattangadi

With few new chemical entities in the pipeline, pharma companies will have devote more attention to managing the life cycle of their brands to derive maximum mileage from existing products.

5.  Lost Patients by Hanno Wolfram

By ignoring the pharmacist, pharma companies are losing out on meeting the health needs of many patients.

Hot this week

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation

The story of Healthium is not just one of...

Topics

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...
spot_img

Related Articles

spot_imgspot_img
Previous article
Next article